FirsthandHealth
medRxiv PreprintsInternational17 November 2026

Patient, carer and clinical stakeholder views on using artificial intelligence and machine learning for the histopathological diagnosis of duodenal biopsies

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Objective: Biopsies are examined under the microscope by a pathologist, giving a diagnosis, which guides treatment and predicts prognosis. A shortage of pathologists and increasing workload leads to diagnostic delays, while for duodenal (small intestinal) biopsies, variable diagnostic concordance between pathologists limits accuracy. These challenges have motivated us to develop an artificial intelligence (AI)-mediated approach for the automated diagnosis of up to 80% of duodenal biopsies (i.e., most cases of the two most frequent diagnoses: coeliac disease and normal). We set out to understan
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.